CagA Antibodies

Santa Cruz Biotechnology offers a broad range of CagA monoclonal antibodies for advanced research in microbiology and cellular signaling. CagA monoclonal antibodies are compatible with multiple techniques, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). CagA, or Cytotoxin-associated gene A, is a virulence factor produced by Helicobacter pylori, a bacterium linked to gastric diseases, including ulcers and cancer. CagA plays a critical role in the pathogenesis of H. pylori by manipulating host cell signaling pathways, leading to inflammation and cellular changes. Understanding CagA function is essential for developing targeted therapies and improving diagnostic methods for H. pylori-related conditions. Researchers worldwide utilize CagA monoclonal antibodies to investigate H. pylori infection mechanisms and host cell responses. Advanced detection methods with CagA monoclonal antibodies enable precise tracking of protein localization and interactions within cells. Ongoing studies with CagA monoclonal antibodies continue to reveal new aspects of bacterial pathogenesis and potential therapeutic targets. Santa Cruz Biotechnology monoclonal antibodies support the scientific community's efforts to advance our understanding of H. pylori-related diseases and develop more effective treatments.